Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
356 participants
INTERVENTIONAL
2021-02-18
2026-10-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The project is composed of four experiments. The first behavioral experiment will investigate how auditory perception is affected by the temporal statistics of past sensory information using artificial stimuli. The second axis will investigate the neural mechanisms underlying auditory timing processing with electroencephalography (EEG). The last Magnetoencephalography (MEG, experiment 3) and EG (rxperiement 4) experiment will test the role of temporal statistics in an ecological setting, namely speech listening. The project will thus provide strong theoretical advances as it will give new insights on brain mechanisms for the processing of complex temporal information in audition and speech, and their role in language comprehension. It will also provide methodological advances. Specifically, the project will contribute to the development and validation of cutting-edge methods in MEG. Namely, it will aim at creating new tools to investigate the neural correlates of auditory and speech processing with an unprecedented temporal and spatial resolution.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Activation During Simple Vocal Behaviors
NCT00071734
Sensory-motor Interactions in the Perception of Vowels: a Study in Repetition - Suppression
NCT03102983
Memory and Attention in Healthy Children
NCT02858752
Elicitation of Steady-state Audiovisual Responses in 6- and 10-month-old Infants
NCT06282289
Dynamic Neural Mechanisms of Audiovisual Speech Perception
NCT04290130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Main study group
All participants signed up for experiment 1, 2, 3 or 4 complete the same protocol (1 study arm) with an intent for intra-subject correlational analyses
Auditory perception tasks in healthy participants
The participants complete auditory perception tasks while EEG, and MEG record brain signals (primary outcome measure). The tasks acquire behavioral responses with button presses (secondary outcome measure).
All analyses are intra-subject (no analyses are between-subject).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Auditory perception tasks in healthy participants
The participants complete auditory perception tasks while EEG, and MEG record brain signals (primary outcome measure). The tasks acquire behavioral responses with button presses (secondary outcome measure).
All analyses are intra-subject (no analyses are between-subject).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18- 40 years old
* Registration with the French healthcare system
* Informed consent
* Normal hearing
Additionally, for experiments 2,3 and 4 :
\- Right handed
Additionally, for experiment 3 and 4:
\- French as native language
Exclusion Criteria
* Neurological or psychiatric illnesses or a history of such problems that could impact quality/variability of data or cooperation and retention of the subject in the study
* Regular use of medications that impact the central nervous system
* Regular use of medications, such as opioids and antidepressants, including SSRIs and tricyclic antidepressants
* Severe hearing loss
* A history of stroke or recent trauma to the head
* Persons unable to adhere to abstinence from the use of drugs or alcohol the day or evening before experimental sessions
* Women who are pregnant, breastfeeding, or have given birth in the last 6 months
Additionally, for experiment 2,3 and 4 :
* A pacemaker, insulin or other pump, neurostimulator, cochlear implants or other hearing aid, metal stents, prosthesis, or implants, intracerebral clips, implantable defibrillator, cerebral shunt or ventricular catheter, other foreign metal objects in the upper part of the body
* any dental apparatus containing metal including or root canals
* any foreign metallic object anywhere in the body
* bolts, screws
* orthopedic devices or implants
Additionally, for experiment 3 and 4:
* claustrophobia
* glasses (given the participant cannot use contact lenses)
* a head size incompatible with the use of a personalized 3D headcast or a magnetoencephalography
* Persons having had any surgery prior to the study which puts them at risk for metal objects left in the body
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne KOSEM, PhD
Role: PRINCIPAL_INVESTIGATOR
Centre de recherche de Neurosciences de Lyon (CRNL)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de Recherche en Neuroscience de Lyon
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01231-38
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL20_0333
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.